Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FL4OWS: Fluoride Delivery Modes in Orthodontics
NCT05005689Phase 4Unknown
- Sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Start
- Oct 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of casein phosphopeptide-amorphous calcium phosphate + fluoride in Tooth demineralization (2 arms), sponsored by Liverpool University Hospitals NHS Foundation Trust. Primary endpoint: New white spot lesions at 2 years. Status: unknown.
02
Drugs
casein phosphopeptide-amorphous calcium phosphate + fluoride
03
Conditions
Tooth demineralization
Beyond the preview
Go deeper on NCT05005689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005689.